TABLE 3

Base-case analysis results for competing strategies

StrategyBase-case estimate
Cost ($)EffectICER
Probability of survivalQALY value$/death averted$/QALY gained
mRDT (with and without ASP)36,301.500.8911.9883−490,763−36,434
mRDT with ASP (A)31,274.240.8911.9883−616,445−45,764
mRDT without ASP (B)57,220.140.9012.123025,7621,913
PCR with ASP (A1)47,917.580.8811.8536−267,148−19,833
MALDI-TOF analysis with ASP (A2)28,394.210.9212.3924−393,397−29,205
PNA-FISH with ASP (A3)53,226.090.8511.449500
BC-GP with ASP (A4)24,904.910.8411.3148DominatedDominated
BC-GN with ASP (A5)33,691.470.9212.3924−317,722−23,587
PCR without ASP (B1)47,430.210.8811.8536−283,394−21,039
PNA-FISH without ASP (B2)58,284.160.9212.392433,6022,495
Conventional laboratory methods with ASP (C)41,723.980.8411.3148DominatedDominated
Conventional laboratory methods without ASP (D)55,932.020.8511.4495BaselineBaseline